Protea Biosciences Group, Inc.
Their common stock is currently traded on the OTCQB marketplace of OTC Markets Group Inc. The last reported sale price of our common stock as reported on the OTCQB on July 13, 2016 was $0.19, which after giving effect to a 1 for 25 reverse stock split described below, equates to $4.75. However, in this prospectus, we assume that the price per share in this offering, on a post-split basis, will be in the range of $4.50 to $6.50, and we have used the midpoint of such range ($5.50) for the assumptions set forth herein.
Last Closing Price
Laidlaw & Company (UK)
To view the prospectus for Protea Biosciences Group, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253